About City of Hope
City of Hope is an independent biomedical research and treatment organization for cancer, diabetes and other life-threatening diseases.
Founded in 1913, City of Hope is a leader in bone marrow transplantation and immunotherapy such as CAR T cell therapy. City of Hope's translational research and personalized treatment protocols advance care throughout the world. Human synthetic insulin, monoclonal antibodies and numerous breakthrough cancer drugs are based on technology developed at the institution. AccessHope , a subsidiary launched in 2019 serves employers and their health care partners by providing access to City of Hope's specialized cancer expertise.
A National Cancer Institute-designated comprehensive cancer center and a founding member of the National Comprehensive Cancer Network, City of Hope is ranked among the nation's Best Hospitals in cancer by U.S. News & World Report and received Magnet Recognition from the American Nurses Credentialing Center. Its main campus is located near Los Angeles, with additional locations throughout Southern California and in Arizona.
City of Hope's commitment to Diversity, Equity and Inclusion
We believe diversity, equity and inclusion is key in serving our mission to provide compassionate patient care, drive innovative discovery, and advance vital education focused on eliminating cancer and diabetes in all of our communities. Our commitment to Diversity, Equity and Inclusion ensures we bring the full range of skills, perspectives, cultural backgrounds and experiences to our work -- and that our teams align with the people we serve in order to build trust and understanding. We are dedicated to fostering a community that embraces diversity - in ideas, backgrounds and perspectives; this is reflected in our work and represented in our people.
The Technology Licensing Manager evaluates the commercial potential of City of Hope developed technologies, identifying companies interested in these technologies and negotiates the legal and business aspects involved in transferring the technology. Establishes and maintains a marketing program that presents City of Hope technologies to appropriate companies.
Key Responsibilities include:
- Maintains an ongoing awareness of the research of the City of Hope national medical Center and Beckman Research Institute and identifies emerging technologies with commercial potential.
- Evaluates City of Hope technologies with respect to the validity of the scientific basis of the technology, strength of the likely patent/copyright/trade secret position, potential commercial return on the technology, and mechanism of commercialization.
- Identifies and maintains a database of companies potentially interested in City of Hope technologies.
- Establishes and maintains a marketing program that presents to appropriate companies those technologies the City of Hope wishes to commercialize.
- Prepares and negotiates the wording in nondisclosure, material transfer, industry sponsored research agreements and license agreements. Interacts closely with involved investigator(s) when preparing agreements.
- Interacts extensively with attorneys and company executives dealing with uncommon inquiries and/or situations.
- Attends meetings as required and participates on committees as directed.
Basic education, experience and skills required for consideration:
- BS with MS or MBA or JD. Experience may substitute for minimum education requirements
- Three years related business and/or academic experience.
Preferred education experience and skills:
- Related field of Science or Business
- As a condition of employment, City of Hope requires staff to comply with all state and federal vaccination mandates.
City of Hope is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, religion, color, national origin, sex, sexual orientation, gender identity, age, status as a protected veteran, or status as a qualified individual with disability.